Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in anatomical structure morphogenesis; cell differentiation; and negative regulation of transcription by RNA polymerase II. Predicted to act upstream of or within hair follicle morphogenesis. Predicted to be located in nucleus. Orthologous to human FOXQ1 (forkhead box Q1).
RGD Description
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including cell differentiation; negative regulation of neuron apoptotic process; and negative regulation of transcription by RNA polymerase II. Predicted to act upstream of or within hair follicle morphogenesis. Predicted to be located in nucleus. Orthologous to human FOXQ1 (forkhead box Q1); INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 17beta-estradiol 3-benzoate.